BOARD OF DIRECTORS

David Melville

Director

Peter Pedro

Director

Cynthia Mazareas

Director

Glen Giovanetti

Director

René Russo

Director

Mike Bonney

Director

Mike Tomsicek

Treasurer & Clerk

Rob Perez

Founder & Chairman

Tim Hunt

Clerk & Director

BOARD OF ADVISORS

Our Board of Directors and Board of Advisors have
committed to covering the administrative expenses of
the organization, so that every dollar we raise can be
put to work fighting poverty.

ABBIE CELNIKER

Third Rock Ventures
Partner

ABE CEESAY

Tiburio Therapeutics
Chief Executive Officer

ADAM GRIDLEY

Histogenics
President & CEO

ADELENE PERKINS

Infinity Pharmaceuticals
President and CEO

ALI FATTAEY

Executive Consulting

ALICIA SECOR

Juniper Pharmaceuticals
Former President & CEO

AMIR NASHAT

Polaris Partners
Partner

ANDREW HIRSCH

Agios Pharmaceuticals
Chief Financial Officer

ANDY MEHROTRA

EightSpokes
Founder & CEO

ANKIT MAHADEVIA

Spero Therapeutics
CEO

BHARATT CHOWRIRA

PureTech Health
President

BILL HEIDEN

AMAG Pharmaceuticals
CEO

BILL HICKS

Mintz Levin
Partner

BILL MCVICAR

Flex Pharma
CEO

BILL SIBOLD

Genzyme
Senior Vice President

BJORN KOCH

UBS
Senior Vice President

BOB COUGHLIN

MassBio
President & CEO

BRIAN JOHNSON

MassMEDIC
President

BRUCE BOOTH

Atlas Ventures
Partner

CHIP CLARK

Genocea
President and CEO

CHRIS GUIFFRE

Pear Therapeutics
CFO & COO

CHRISTOPH WESTPHAL

Longwood Fund
General Partner

COLIN HILL

GNS Healthcare
CEO, Chairman and Co-Founder

DANIEL GEFFKEN

Danforth Advisors
Managing Director

DANIEL LYNCH

bluebird bio
Chairman

DAVE MELLO

The Richmond Group
President

DAVID LUCCHINO

Frequency Therapeutics
CEO

DAVID MEEK

Ipsen
CEO

DAVID MEEKER

KSQ Therapeutics

President & CEO

DEBORAH DUNSIRE

Lundbeck
President & CEO

DEE DEE DEMAN

Bench International
Chairman & CEO

DEVAL PATRICK

Bain Capital
Managing Director

DONNA HIGGINS

The Higgins Group
President & CEO

DONNA LAVOIE

LavoieHealthScience

CEO

DOUG INGRAM

Sarepta

CEO

DOUGLAS FAMBROUGH

Dicerna
CEO

DOUGLAS PAGAN

KSQ Therapeutics
CFO

EDDIE MARTUCCI

Akili Interactive
CEO

EDWARD DOWNEY

Plimouth Rock Risk Consulting
Principal

ELAN EZICKSON

Scholar Rock, Inc
COO and Head, Corporate Development(Retired)

ELISABET DE LOS PINOS

Aura Biosciences
CEO

ELIZABETH WAGNER

Constant Pharmaceuticals
COO

ERIC KIMBLE

Entasis Therapeutics

Chief Commercial Officer

ERIC LANDER

Broad Institute

President & Founding Director

FRANK THOMAS

Orchard Therapeutics
CFO & CBO

GARY ZIEZIULA

GEOFFREY MCDONOUGH

Generation Bio
President & CEO

GREG ERMAN

EmpiraMed, Inc.
CEO

GREG MADISON

Melt Pharmaceuticals
CEO

HALLEY GILBERT

Ironwood Pharmaceuticals
Senior Vice President & Chief Legal Officer

HUGH COLE

Jounce Therapeutics
Chief Business Officer & Head of Corporate Development

IVANA MAGOVCEVIC-LIEBISCH

Ipsen
EVP & Chief Business Officer

IYA KHALIL

GNS Healthcare
CCO & Co-Founder

JEAN GEORGE

Lightstone Ventures
General Partner

JEB KEIPER

Nimbus Therapeutics
CEO

JEFF LEERINK

SVB Leerink
CEO

JEFF LEIDEN

Vertex
Chairman, President and CEO

JEFFREY HEMMAN

PwC

Partner

JIGAR RAYTHATHA

Constellation Pharmaceuticals
CEO

JOE VITTIGLIO

AMAG Pharmaceuticals
Executive Vice President and General Counsel

JOE VON RICKENBACH

Parexel
Co-Founder & Chairman

JOEP MUIJRERS

PureTech Health
Chief Financial Officer

JOHN FREY

First Republic Bank
Managing Director, Foreign Exchange

JOHN GLASSPOOL

Anthos Therapeutics
CEO

JOHN MARAGANORE

Alnylam
CEO

JON BOLLA

Lantheus Medical Imaging

Chief Operations Officer

KATIE MCCARTHY

Halloran Consulting Group
Managing Director

KEVIN BITTERMAN

Atlas Ventures
Partner

KURT GRAVES

Intarcia
Chairman, President and CEO

KUSH PARMAR

5AM Ventures
Managing Partner

LAURENCE REID

LESLIE ORNE

Trinity
Senior Partner

LESLIE WILLIAMS

ImmusanT, Inc
CEO

LONNIE MOULDER

TESARO, Inc
CEO

MARC BEER

Renovia
CEO

MARC KOZIN

L.E.K. Consulting
Senior Advisor

MARIAN NAKADA

J&J
Vice President, Venture Investments

MARK BAMFORTH

Brammer Bio
President & CEO

MARK LEVIN

Third Rock Ventures
Partner

MARK STEJBACH

Flexion Therapeutics
Board Member

MARY THISTLE

Bill & Melinda Gates Foundation
Chief of Staff

MAURA HODGE

KPMG
Partner

MICHAEL HANEWICH

Silicon Valley Bank
Managing Director

MICHAEL HEFFERNAN

Collegium Pharmaceuticals
Chairman

MICHAEL MAGUIRE

Putnam Investments
Healthcare Analyst

MICHAEL STANSKY

Tudor Investment
Managing Director (Retired)

MICHEL VOUNATSOS

Biogen
CEO

MICHELLE DIPP

General Atlantic
Managing Director

MIKE DONOVAN

EY
Managing Partner- Cambridge

MIKE GRAY

Imara
Chief Financial & Chief Operating Officer

MIKE O’HARA

Deloitte
Partner

MITCH BLOOM

Goodwin Procter LLP
Partner

NANCY SIMONIAN

Syros Pharmaceuticals
CEO

NEAL DUNN

Trinity Partners
Partner

NICK GALAKATOS

Blackstone
Senior Managing Director

OTELLO STAMPACCHIA

Omega Funds
Founder

PARIS PANAYIOTOPOULOS

Clarus Funds
Operating Partner

PATRICIA ANDREWS

Boston Biomedical
CEO

PAUL ENDERLE

Baycross Capital Group, LLC
Managing Director

PAULA SOTEROPOULOS

Akcea Therapeutics
CEO

PETER BARRETT

Atlas Ventures
Partner

PETER HECHT

Ironwood Pharmaceuticals
CEO

PETER LATHAM

Latham BioPharm Group
CEO

PIERRE JACQUET

L.E.K. Consulting
Managing Director & Partner

PJ ANAND

Alcyone Lifesciences
Founder & CEO

PRAVEEN TIPIRNENI

Morphic Therapeutic
CEO

RAJEEV VENKAYYA

Takeda
President, Global Vaccines Business Unit

RAMI LEVIN

Sobi North America
President

RICH ALDRICH

Longwood
General Partner

RICHARD KERTZMAN

First Republic Bank
Managing Director

ROB BAZEMORE

Epizyme
President and CEO

ROBERT FORRESTER

Verastem
President & CEO

ROBERT URBAN

Johnson & Johnson Innovation
Global Head (Retired)

RON COOPER

Albireo Pharma
President & CEO

ROY HIRSHLAND

T3 Advisors
CEO, Co-Founder

RUSSELL HERNDON

Hydra Biosciences
President

STEPHANE BANCEL

Moderna
CEO

STEVE CARBONNEAU

The Richmond Group
President

STEVE HOLTZMAN

Decibel Therapeutics
President & CEO

STUART CABLE

Goodwin Procter LLP
Partner

STUART RANDLE

Ivenix
President and CEO

SUSAN NEMETZ

The NemetzGroup LLC
Principal

TED MYLES

AMAG Pharmaceuticals
Executive Vice President & Chief Financial Officer

THOMAS CAREY

Perspective Group
Founder & Managing Partner

THOMAS DESROSIER

Seres Therapeutics
Executive Vice President & Chief Legal Officer

TIM EHRLICH

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian

Partner

TIMOTHY THOMPSON

Aptus
CEO

TOM ANDREWS

Alexandria Real Estate Equities
Executive Vice President

TONY COLES

Yumanity
Chairman and CEO

TRAVIS MCCREADY

Mass. Life Sciences Center
President and CEO

WENDY ERLER

Alexion
VP, Head of STAR Patient Insights and Advocacy

ZOE BARRY

ZappRx
Founder & CEO

ZOLTAN CSIMMA

Senior Biotech Executive

We are also extremely grateful to the generous companies who have provided pro bono services to help in the fight against poverty in greater Boston, including: